Evaluation of Optical Coherence Tomography Angiography Parameters following use of Anti vascular endothelial growth factor in Non resolving Central Serous Chorioretinopathy - NIl

Maulana Azad Medical college0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1)Treatment naïve subjects in the age group of 25-50 years having non resolving central serous chrioretinopathy of more than four months duration along with subretinal fluid (SRF) involving fovea on optical coherence topography (oct) and active angiographic leakage of fundus fluorescein angiography (FFA)
•2)Subject having best corrected visual acuity (BCVA) of at least 6/60

•1)patients having ocular conditions causing accumulation of sub-retinal fluid like diabetic retinopathy,retinal vascular occlusion,ocular inflammation or ocular conditions causing macular exudation such as pathological myopia and antioxidants streaks
•2)patients who have undergone any intraocular surgery other than uncomplicated cataract extraction
•3)Risk of thrombo-emboli events and/or occurrence within past 6 months

发起方